Aadi Biosciences (AADI.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Mar12

Aadi Biosciences to Release FY2024 Q4 Earnings on March 19 During-Market EST, Forecast Revenue 7.45 M USD, EPS -0.295 USD

00:05

Mar3

All Proposals Approved at Aadi Bioscience Inc. Special Shareholder Meeting

14:40

Feb5

Aadi proposes to sell FYARRO and related infrastructure to Kaken for $100 million

21:27

Nov7

Aadi Biosciences released FY2024 9 Months Earnings on November 6 After-Market EST, with actual revenue of 18,744,000 USD and EPS of -1.6817

00:00

Aadi Biosciences released FY2024 Q3 earnings on November 6 After-Market (EST), actual revenue $7.212M (forecast $6.596M), actual EPS -0.4639 (forecast -0.4575)

00:00

Oct30

Aadi Biosciences to Release FY2024 Q3 Earnings on November 6 After-Market EST, Forecast Revenue 6.596 M USD, EPS -0.4575 USD

01:23

Schedules & Filings

Schedules

Filings

Mar19

Ticker Change(EST)

From 03.19 changed to WHWK

Nov6

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 7.212 M, Net Income -12.55 M, EPS -0.4639

Aug7

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 6.179 M, Net Income -14.58 M, EPS -0.5399

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More